Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › INDGN

INDGN

Indegene Limited
Small-capHealthcare ↗

What the six lenses say about INDGN — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹495.9
2026-07-10
VWAP · 1Y anchor
₹526
-5.7% from VWAP
P/E · TTM
29.7×
TTM EPS ₹16.7
52-week range
44%
position low→high
RSI(14)
39
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How INDGN’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD448›

The actual numbers

Price vs VWAP (1y)-5.7%
EMA trend stackMixed
Price vs 200-EMA-3.7%
Price vs 50-EMA-2.7%
RSI(14)39
RS vs Nifty 500 · 3M-2.1%
RS vs sector · 3M-13.7%
52-week range44%
Volume vs 30d avg1.75×
Volume vs 60d avg1.71×
ATR(14) · volatility17.6
Bollinger width · vol contraction0.101
FundamentalD867›

The actual numbers

Return on equity (ROE)14.4%
Return on capital (ROCE)18.8%
Operating margin15.5%
Net margin11.4%
Revenue growth · YoY+23.6%
EPS growth · YoY-2.5%
Debt / equity0.05×

Full 8-quarter history in the financials table below.

ValuationD742›

The actual numbers

P/E (TTM)29.7×
TTM EPS₹16.7
52-week range44%
CatalystD848›

The actual numbers

Earnings & momentum36
Capital actions43
Governance116

Every filing in the corporate-announcements panel below.

FlowD650›

The actual numbers

Promoter holding0.0%
Delivery · 30d avg56.2%
Up/down-day asymmetry2.9pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D4 + D6 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
48
Conviction score 48/100 · avg-decile strength 5.0/10
Conviction score48/100›
TechnicalD4›
FundamentalD8›
ValuationD7›
CatalystD8›
FlowD6›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.1pp
-2.7pp
-7.6pp
+1.5pp
+4.0pp
-7.6pp
Nifty 500
Broad-market baseline
-0.3pp
-2.8pp
-8.2pp
-2.1pp
-1.1pp
-11.4pp
Sector
Own-sector index
—
—
-9.9pp
-13.7pp
-13.9pp
-25.9pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

INDGN daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
495.95+2.25

Relative strength

RS vs baseline · rebased to 100

INDGN ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
86.63-0.26

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)6776877207567618049421,003
↳ change QoQ—+1.5%+4.9%+4.9%+0.7%+5.7%+17.2%+6.5%
EBITDA (₹cr)151148170148155141160164
EBITDA margin22.4%21.5%23.5%19.6%20.4%17.5%17.0%16.4%
PAT (₹cr)889211011811610210380
↳ change QoQ—+4.6%+19.6%+7.6%-1.7%-12.1%+1.0%-22.3%
Net margin13.0%13.4%15.2%15.6%15.2%12.7%10.9%8.0%
EPS (₹)3.793.844.594.904.854.254.283.31
D/E————————
YoY growth · Mar '26Revenue +32.7% YoYPAT -32.2% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 12 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 May '26
    LOWgovernance
    Action(s) initiated or orders passed
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Allotment of Securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds INDGN

Mutual funds holding INDGN (10)

FundWeightAUM ₹crGrade
Sundaram Mid Cap Gr0.60%13,687
ICICI Pru Technology Gr0.78%13,358
ICICI Pru Smallcap Instl Gr0.54%8,949
ICICI Pru Smallcap Gr0.54%8,949
Helios Flexi Cap Reg Gr0.67%7,094
SBI Technology Opportunities Reg Gr1.17%4,018
Sundaram Flexi Cap Reg Gr1.08%1,962
Helios Mid Cap Reg Gr0.83%1,490
Sundaram ELSS Tax Saver Reg Gr1.11%1,263
Helios Small Cap Reg Gr0.87%1,037

ETFs holding INDGN (0)

No tracked ETF holds INDGN ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare